帕奇桑德拉物种:植物化学,药理学和合成先进-一个迷你评论
Nguyen Manh Ha1, Le The Hoai1, Ninh The Son2
1Faculty of Chemical Technology, Hanoi University of Industry, Hanoi, Vietnam.
Chemistry & biodiversity
|February 7, 2025
概括
帕奇桑德拉植物含有140多种代谢物,包括类固醇化物. 这些化合物显示出潜在的抗癌和抗微生物活性,合成版本更强效.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 医学植物学 医学植物学
背景情况:
- 帕奇桑德拉,Buxaceae家族的一个属,包括药用植物.
- 它的植物化学和药理性质对药物发现具有重大兴趣.
研究的目的:
- 详细介绍帕奇桑德拉物种的植物化学和药理学活动.
- 识别关键代谢物并评估它们的治疗潜力.
主要方法:
- 从Pachysandra中分离和识别了140多种代谢物.
- 类固醇类化合物,类固醇,三类化合物和其他化合物的表征.
- 药理学活动的评估,包括抗癌,抗微生物和抗雌激素作用.
主要成果:
- 类固醇类化合物,特别是孕妇骨,是被确定的主要化合物.
- 新的化合物被发现,除了已知的代谢物,如醇和酸盐.
- 帕奇桑德拉的类固醇类化合物表现出抗癌,抗菌,抗雌激素和胃保护作用.
- 与天然分离物相比,合成的帕奇桑德拉类固醇化物表现出增强的细胞毒性作用.
结论:
- 帕奇桑德拉是一种丰富的多样化代谢物的来源,具有显著的治疗潜力.
- 类固醇类化合物是关键的生物活性化合物,其结构修改影响药理结果.
- 对帕奇桑德拉类化合物的进一步研究可能会导致针对各种疾病的新药开发.
相关概念视频
Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Prodrugs
4.1K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.1K
Bioavailability Enhancement: Drug Solubility Enhancement
499
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
499
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Pharmacogenetics of Drug Metabolism: Overview
194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194


